Chemical Structure Of Zileuton (3c61db22 C5f4 45c8 9ace 386dd4267c12 01)
Zileuton Tablet, Multilayer, Extended Release
Product Images NDC 64380-189
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zileuton (NDC 64380-189). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1. Mean Change From Baseline In Trough Fev1 In 12-week Clinical Trial In Patients With Asthma. (3c61db22 C5f4 45c8 9ace 386dd4267c12 02)
Image (3c61db22 C5f4 45c8 9ace 386dd4267c12 03)
This is a medication description that includes dosage and storage information for Zileuton Extended-Release Tablets. Each tablet contains 600mg of zileuton and users should not chew, cut, or crush them. The medication should be stored between 20°-25°C (68°-77°F), in a USP tight, light-resistant container, and protected from light. The packaging also includes a Non-printing dieline, a Nonvarnished area, and a product identification barcode. The medication is prescription-only and should be kept out of reach of children. If seal over the bottle opening is broken or missing, do not accept. The medication is distributed by Strides Pharma Inc, and it comes in a 120 tablet bottle.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
